Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

In a report released today, Peter Welford from Jefferies maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

After Tokyo-based holding company Lucozade Ribena Suntory (LRS) bought the Lucozade and Ribena brands from Glaxo Smith Kline in September 2013 for £1.35bn, the latest results seem to underline a smart ...

The South African Communist Party (SACP) in the Western Cape has learnt that several employees who work for Glaxo Smith Kline (GSK) pharmaceutical company based in Epping, Cape Town, have tested ...

A molecular biologist has warned of the dangers of the 5:2 fasting diet after developing motor neurone disease. Dr Vivienne ...

GSK has demonstrated robust sales growth, with a 13% increase to GBP 7.9 billion and a core operating profit up by 21% to GBP 2.5 billion, as noted by CEO Emma Walmsley in the latest earnings call.

Credit: CeltStudio/Shutterstock. Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review GSK‘s new drug application (NDA) for Blenrep (belantamab mafodotin) to treat patients ...

Kansas City Chiefs tight end Travis Kelce has started the 2024 season slower than what fans would have expected going into the year. After a ninth Pro Bowl season, Kelce has only gotten seven ...

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

An analysis of data from the phase 2 portion of the trial showed the primary efficacy objective had not been met. A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine ...

High response rates reported by GSK and iTeos at the 2024 European Society for Medical Oncology Congress offer a ray of light for anti-TIGIT therapies after a string of failures. GSK and iTeos ...